Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons

Journal of Physiology

Volumn 588, Issue 14, 2010, Pages 2589-2604

  Haj Dahmane, Samir ^a   Shen, Roh Yu ^a  

^a RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOCANNABINOID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; DOPAMINE; NIFEDIPINE; PHOSPHOLIPASE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINERGIC NERVE CELL; FATTY ACID SYNTHESIS; LONG TERM DEPRESSION; MESENCEPHALON; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROBABILITY; RAT; SENSORY NERVE; SENSORY STIMULATION; SIGNAL TRANSDUCTION; SYNAPSE; VENTRAL TEGMENTUM; BIOSYNTHESIS; GLUTAMATERGIC SYNAPSE; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE STIMULATION; REGULATORY MECHANISM; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; ENDOCANNABINOIDS; GLUTAMIC ACID; GLYCERIDES; LONG-TERM SYNAPTIC DEPRESSION; MALE; MESENCEPHALON; NEURONAL PLASTICITY; NEURONS; NIFEDIPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; SYNAPTIC TRANSMISSION; TYPE C PHOSPHOLIPASES; VENTRAL TEGMENTAL AREA; CANNABINOID RECEPTOR MODULATORS;

EID: 77954730199     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.190066     Document Type: Article

References (53)

1. Bellone C, Lüscher C. mGluRs induce a long-term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors. Eur J Neurosci 2005, 21:1280-1288.
2. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Diherty P. Cloning of the first sn1-DGLs points to the spatial and temporal regulation of endocannabinoid signalling in the brain. J Cell Biol 2003, 163:463-468.
3. Chapin EM, Andrade R. A 5-HT7 receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current Ih. J Pharmacol Exp Ther 2001, 297:403-409.
4. Chavez-Noriega LE, Stevens CF. Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices. J Neurosci 1994, 14:310-317.
5. Chevaleyre V, Castillo PE. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 2003, 38:461-472.
6. Chevaleyre V, Heifets BD, Kaeser PS, Südhof TC, Castillo PE. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signalling and RIM1α. Neuron 2007, 54:801-812.
7. Christie MJ, Bridge S, James LB, Beart PM. Excitotoxin lesions suggest aspartatergic projections from rat medial prefrontal cortex to ventral tegmental area. Brain Res 1985, 333:169-172.
8. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. Formation and inactivation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
9. Drummond GB. Reporting ethical matters in The Journal of Physiology. J Physiol 2009, 587:713-719.
10. Durante P, Cardenas CG, Whittaker JA, Kitai ST, Scroggs RS. Low-threshold L-type calcium channels in rat dopamine neurons. J Neurophysiol 2004, 91:1450-1454.
11. Fougeaud L, Mato S, Bouchet D, Hemar A, Worley PF, Manzoni OJ. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J Neurosci 2004, 24:6939-6945.
12. Geisler S, Wise RA. Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci 2008, 19:227-244.
13. Georges F, Aston-Jones G. Potent regulation of midbrain dopamine neurons by the bed nucleus of the striata terminalis. J Neurosci 2001, 21:RC160.
14. Gerdeman P, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 2002, 5:446-451.
15. Gutlerner JL, Chapin Penick E, Snyder EM, Kauer JA. Novel protein kinase A-dependent long-term depression of excitatory synapses. Neuron 2002, 36:921-931.
16. Haj-Dahmane S, Shen RY. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signalling. J Neurosci 2005, 25:896-905.
17. Haj-Dahmane S, Shen RY. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. J Pharmacol Exp Ther 2009, 331:186-196.
18. Heifets BD, Castillo PE. Endocannabinoid signalling and long-term synaptic plasticity. Annu Rev Physiol 2009, 71:283-306.
19. Hoover HS, Blankman JL, Niessen S, Cravatt BF. Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Let 2008, 18:5838-5841.
20. Howlett AC, Qualy JM, Khachatrian LL. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 1986, 29:307-313.
21. Jones S, Kornblum JL, Kauer JA. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J Neurosci 2000, 20:5575-5580.
22. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoids-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
23. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci 2007, 8:844-858.
24. Kim J, Isokawa M, Ledent C, Alger BE. Activation of muscarinic acetylcholine receptors enhances the release if endogenous cannabinoids in the hippocampus. J Neurosci 2002, 22:10182-10191.
25. Kraushaar U, Jonas P. efficacy and stability of quantal GABA release at a hippocampal interneuron-principal neuron synapse. J Neurosci 2000, 20:5594-5607.
26. Kreitzer AC, Malenka RC. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci 2005, 25:10537-10545.
27. Kreitzer AC, Regehr WG. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto the purkinje cells. Neuron 2001, 29:717-727.
28. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoids receptors. Neuron 2001, 31:463-475.
29. Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 2006, 29:225-232.
30. Malenka RC, Bear MF. LTP and LTD: An embarrassment of riches. Neuron 2004, 44:5-21.
31. Margolis EB, Lock H, Hjelmstad GO, Fields HL. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J Physiol 2006, 577:907-924.
32. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
33. Mátyás F, Urbán GM, Watanabe M, Mackie K, Zimmer A, Freund TF, Katona I. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signalling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
34. Melis M, Pistis M, Perra S, Muntoni AL, Pillola G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004a, 24:53-62.
35. Melis M, Perra S, Muntoni AL, Pillola G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol- mediated suppression of excitation in dopamine neurons. J Neurosci 2004b, 24:10707-10715.
36. Ohno-Shosaku T, Maejima M, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-739.
37. Overton PG, Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev 1997, 25:312-334.
38. Pan B, Hillard CJ, Liu QS. Endocannabinoid signalling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci 2008, 28:1385-1397.
39. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
40. Riegel AC, Lupica CR. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signalling at multiple synapses in the ventral tegmental area. J Neurosci 2004, 24:11070-11078.
41. Robbe D, Koft M, Remaury A, Bockaert J, Manzoni OJ. Endogenous cannabinoids mediate long-term-depression in the nucleus accumbens. Proc Natl Acad Sci U S A 2002, 99:8384-8388.
42. Schultz W, Dayan P, Montague PR. A neuronal substrate of prediction and reward. Science 1997, 275:1593-1599.
43. Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005, 85:1303-1342.
44. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
45. Sugiura T, Kobayashi Y, Oka S, Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 2002, 66:173-192.
46. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Baer WU, Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 2006, 577:263-280.
47. Thomas MJ, Malenka RC, Bonci A. Modulation of long-term depression by dopamine in the mesolimbic system. J Neurosci 2000, 20:5581-5586.
48. Tzounopoulos T, Janz R, Südhof TC, Nicoll RA, Malenka RC. A role of cAMP in long-term depression at hippocampal mossy fibre synapses. Neuron 1998, 21:837-845.
49. Wang J, Haj-Dahmane S, Shen RY. Effects of prenatal ethanol exposure on the excitability of ventral tegmental area dopamine neurons in vitro. J Pharmacol Exp Ther 2006, 319:857-863.
50. Wightman RM, Robinson DL. Transient changes in mesolimbic dopamine and their association with 'reward'. J Neurochem 2002, 82:721-735.
51. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
52. Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
53. Yasuda H, Huang Y, Tsumoto T. Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus. Proc Natl Acad Sci U S A 2008, 105:3106-3111.